On February 15 this year. new Summary of Product Characteristics for COMIRNATY has been approved.
- Comirnates, 30 micrograms/dose, concentrate for dispersion for injection (with purple cap) and
- Comirnates, 10 micrograms/dose, concentrate for dispersion for injection (with orange cap).
The changes ...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
